Biotechnology Research

22:48 EDT 16th October 2018 | BioPortfolio

The physiology and biotechnology of dark fermentative biohydrogen production.

A CO-neutral energy production alternative compared to conventional fossil fuel utilization is biohydrogen (H) production. Three basic mechanisms for microbial H production exist: photosynthetic H production, photo-fermentative H production, and dark fermentative H production (DFHP). Despite surmounting reports in literature on the characterization and optimization of DFHP systems, H production ha...

Novel approaches and reasons to isolate methanotrophic bacteria with biotechnological potentials: recent achievements and perspectives.

The recent drop in the price of natural gas has rekindled the interests in methanotrophs, the organisms capable of utilizing methane as the sole electron donor and carbon source, as biocatalysts for various industrial applications. As heterologous expression of the methane monooxygenases in more amenable hosts has been proven to be nearly impossible, future success in methanotroph biotechnology la...

Gender disparities among independent fellows in biomedical research.

Decoding mood.

FDA approves Galafold, a triumph for Amicus.

The virome hunters.

Biotech leaders call for free press.

Akcea's antisense drug rejection worries analysts.

Around the world in a month.


This corrects the article DOI: 10.1038/nbt0818-671.

Author Correction: Precision medicine in the clouds.

This corrects the article DOI: 10.1038/nbt.4210.

Smart insulin: redesign could end hypoglycemia risk.

In defense of the press... and more.

Setbacks shadow microRNA therapies in the clinic.

Designing efficient translation.

Regeneron buys into CAR-Ts with Bluebird Bio deal.

Barcodes galore for developmental biology.

Publisher Correction: Guided self-organization and cortical plate formation in human brain organoids.

This corrects the article DOI: 10.1038/nbt.3906.

Recent patents in antimicrobials.

Sangamo's landmark genome editing trial gets mixed reception.

Opening options for material transfer.

US law threatens flow of foreign capital to biotech sector.

Are the new clinical trial transparency rules incompatible with the patentability requirements in Europe?

A Crispr Future for Gene-Editing Regulation: a Proposal for an Updated Biotechnology Regulatory System in an Era of Human Genomic Editing.

Recent developments in gene-editing technology have enabled scientists to manipulate the human genome in unprecedented ways. One technology in particular, Clustered Regularly Interspaced Short Pallindromic Repeat (CRISPR), has made gene editing more precise and cost-effective than ever before. Indeed, scientists have already shown that CRISPR can eliminate genes linked to life-threatening diseases...

Safety of the fungal workhorses of industrial biotechnology: update on the mycotoxin and secondary metabolite potential of Aspergillus niger, Aspergillus oryzae, and Trichoderma reesei.

This review presents an update on the current knowledge of the secondary metabolite potential of the major fungal species used in industrial biotechnology, i.e., Aspergillus niger, Aspergillus oryzae, and Trichoderma reesei. These species have a long history of safe use for enzyme production. Like most microorganisms that exist in a challenging environment in nature, these fungi can produce a larg...

Quick Search


review and buy Biotechnology market research data and corporate reports here